Edges in Network
Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
Node | VEGFB |
Upstream (Parents) |
---|
(<<) ATF2 → VEGFB |
(<<) DNM3 → VEGFB |
(<<) GRN → VEGFB |
(<<) MYL6B → VEGFB |
(<<) MYL9 → VEGFB |
(<<) NFATC3 → VEGFB |
(<<) PLD3 → VEGFB |
(<<) PPIB → VEGFB |
(<<) PPP1CA → VEGFB |
(<<) RAC1 → VEGFB |
(<<) SH3GLB2 → VEGFB |
(<<) SP3 → VEGFB |
(<<) ST3GAL6 → VEGFB |
(<<) TAGLN2 → VEGFB |
(<<) VPS37B → VEGFB |
Downstream (Children) |
---|
VEGFB → ATN1 (>>) |
VEGFB → CDR2 (>>) |
VEGFB → CEBPA (>>) |
VEGFB → GALR3 (>>) |
VEGFB → GNAI3 (>>) |
VEGFB → HNF1A (>>) |
VEGFB → ITGB5 (>>) |
VEGFB → PITPNA (>>) |
VEGFB → SOX18 (>>) |
VEGFB → TGM2 (>>) |
VEGFB → TMEM39B (>>) |
VEGFB → UBE2D4 (>>) |
VEGFB → VPS28 (>>) |